The importance of 'Mechnikov's thorn' for an improved understanding of 21st century medicine and immunology: A view from the eye

Scandinavian Journal of Immunology

Volumn 68, Issue 2, 2008, Pages 129-139

  McGonagle, D ^a,b   Georgouli, T ^c  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; HLA B27 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CROHN DISEASE; EYE DISEASE; HISTORY OF MEDICINE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SYMPATHETIC OPHTHALMIA; TISSUE DEGENERATION; ULCERATIVE COLITIS;

ALLERGY AND IMMUNOLOGY; ANIMALS; AUTOIMMUNE DISEASES; EYE DISEASES; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS;

EID: 47149118332     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02114.x     Document Type: Review

References (73)

1. Albert DM, Diaz-Rohena R. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol 1989 34 : 1 14.
2. Niederkorn JY. The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy 2007 92 : 27 35.
3. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001 345 : 340 50.
4. http://nobelprize.org/nobel_prizes/medicine/laureates/1908.
5. Germain RN. An innately interesting decade of research in immunology. Nat Med 2004 10 : 1307 20.
6. O'Neill LA. TLRs: Professor Mechnikov, sit on your hat. Trends Immunol 2004 25 : 687 93.
7. McGonagle D, McDermott MF. A Proposed Classification of the Immunological Diseases. PLoS Med 2006 3 : e297.
8. McGonagle D, Savic S, McDermott MF. The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self. Semin Immunopathol 2007 29 : 303 13.
9. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006 440 : 237 41.
10. Burroughs JR, Bearden WH, Anderson RL, Hoffman RO, Elliot RL, McCann JD. Congenitally enlarged extraocular muscles: can congenital thyroid eye disease exist in a euthyroid infant? Ophthal Plast Reconstr Surg 2006 22 : 314 6.
11. Meyer O. Anti-SSA/Ro and anti-SSB/La antibodies. What's new? Ann Med Interne (Paris) 2002 153 : 520 9.
12. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004 50 : 380 6.
13. McClain MT, Arbuckle MR, Heinlen LD et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004 50 : 1226 32.
14. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004 117 : 39 50.
15. Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 2001 30 : 217 41.
16. Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol 2005 50 : 351 63.
17. Clewes AR, Dawson JK, Kaye S, Bucknall RC. Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics. Ann Rheum Dis 2005 64 : 961 2.
18. Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 2002 120 : 15 9.
19. McKibbin M, Clark B, Isaacs JD et al. Does the shared epitope genotype influence either the susceptibility to or the phenotype of corneal melting? Eye 2001 15 : 492 6.
20. John SL, Morgan K, Tullo AB, Holt PJ. Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis. Eye 1992 6 : 630 6.
21. Sule A, Balakrishnan C, Gaitonde S et al. Rheumatoid corneal melt. Rheumatology (Oxford) 2002 41 : 705 6.
22. Edwards JC, Blades S, Cambridge G. Restricted expression of Fc gammaRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA). Clin Exp Immunol 1997 108 : 401 6.
23. van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol 2005 175 : 5575 80.
24. Chowers I, Siganos CS, Solomon A, Frucht-Pery J. Deep stromal inflammation - a possible new ocular manifestation of Crohn's disease. Ocul Immunol Inflamm 1998 6 : 59 62.
25. Gorrono-Echebarria MB, Albarran F, Marcos A, Alvarez-Mon M. Inflammatory bowel disease (Crohn's disease) in a Spanish patient with pars plana exudates: report of a new case and review of the literature. Ocul Immunol Inflamm. 2002 10 : 65 8.
26. Levine AD, Fiocchi C. Immunology of inflammatory bowel disease. Curr Opin Gastroenterol. 2000 16 : 306 9.
27. Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol. 1982 14 : 356 60.
28. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. GETAID Am J Med Genet 1994 52 : 207 13.
29. Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007 39 : 830 2.
30. Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D. Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum 2007 56 : 224 33.
31. Benjamin M, McGonagle D. Histopathologic changes at 'synovio-entheseal complexes' suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum 2007 56 : 3601 9.
32. Bhalerao J, Bowcock AM. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet 1998 7 : 1537 45.
33. Mohla G, Brodell RT. Koebner phenomenon in psoriasis. A common response to skin trauma. Postgrad Med 1999 106 : 39 40.
34. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A streptococcus. J Invest Dermatol 2001 117 : 91 7.
35. Heilborn JD, Nilsson MF, Kratz G et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003 120 : 379 89.
36. Itoh Y, Inoko H, Kulski JK et al. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens 2006 67 : 390 4.
37. Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Tissue Antigens 2004 64 : 293 7.
38. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005 17 : 586 99.
39. Gilhar A, Winterstein G, Turani H, Landau J, Etzioni A. Skin hyperreactivity response (pathergy) in Behcet's disease. J Am Acad Dermatol 1989 21 : 547 52.
40. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005 50 : 364 88.
41. McGonagle D, Stockwin L, Isaacs J, Emery P. An enthesitis based model for the pathogenesis of spondyloarthropathy. Additive effects of microbial adjuvant and biomechanical factors at disease sites. J Rheumatol 2001 28 : 2155 9.
42. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980 286 : 611 3.
43. Matzinger P. The danger model: a renewed sense of self. Science 2002 296 : 301 5.
44. Gray DH, Gavanescu I, Benoist C, Mathis D. Danger-free autoimmune disease in Aire-deficient mice. Proc Natl Acad Sci U S A 2007 104 : 18193 8.
45. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003 349 : 1526 33.
46. Ganesan S, Travis SP, Ahmad T, Jazrawi R. Role of tumor necrosis factor in Crohn's disease. Curr Opin Investig Drugs 2002 3 : 1297 300.
47. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004 430 : 257 63.
48. Manouvrier-Hanu S, Puech B, Piette F et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet 1998 76 : 217 21.
49. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005 308 : 421 4.
50. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004 122 : 598 614.
51. Brown DM, Kaiser PK, Michels M et al ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006 355 : 1432 44.
52. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004 351 : 2805 16.
53. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006 7 : 354 9.
54. Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin Ophthalmol 2005 20 : 191 7.
55. Lin X, Li S, Xie C, Huang X, Fan Z. Experimental studies of melanin associated antigen and its relationship with sympathetic ophthalmia and Vogt-Kayanagi-Harada syndrome. Yan Ke Xue Bao 2003 19 : 184 6, 200.
56. Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 1985 92 : 1025 8.
57. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995 39 : 265 92.
58. Chan CC. Relationship between sympathetic ophthalmia, phacoanaphylatic endophthalmitis, and Vogt-Koyanagi-Harada disease. Ophthalmology 1988 95 : 619 24.
59. Arellanes-Garcia L, Bautista N, Mora P, Ortega-Larrocea G, Burguet A, Gorodezky C. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm 1998 6 : 93 100.
60. Weisz JM, Holland GN, Roer LN et al. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology 1995 102 : 1012 5.
61. Yamada K, Senju S, Shinohara T et al. Humoral immune response directed against LEDGF in patients with VKH. Immunol Lett 2001 78 : 161 8.
62. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999 42 : 1080 6.
63. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 1997 123 : 70 5.
64. Amirzargar AA, Tabasi A, Khosravi F et al. Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study. Eur J Neurol 2005 12 : 25 30.
65. Barnett MH, Sutton I. The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 2006 19 : 242 7.
66. Antel JP, Bar-Or A. Do myelin-directed antibodies predict multiple sclerosis? N Engl J Med 2003 349 : 107 9.
67. Adamus G, Chan CC. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol 2002 21 : 209 29.
68. Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001 9 : 93 102.
69. Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004 12 : 137 42.
70. Bron A, Tripathi RC, Tripath BJ. The nerve fiber layer. In : Bron A, Tripathi RC, Tripath BJ, eds. Wolff's Anatomy of the Eye and Orbit, 8th edn. London : Arnold AH, 1997 : 485 7.
71. Kuhle J, Pohl C, Mehling M et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007 356 : 371 8.
72. Sriram S, Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 2005 58 : 939 45.
73. Zinkernagel R. On observing and analyzing disease versus signals. Nat Immunol. 2007 8 : 8 10.